IL84409A - Imidazolidinone derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

Imidazolidinone derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL84409A
IL84409A IL84409A IL8440987A IL84409A IL 84409 A IL84409 A IL 84409A IL 84409 A IL84409 A IL 84409A IL 8440987 A IL8440987 A IL 8440987A IL 84409 A IL84409 A IL 84409A
Authority
IL
Israel
Prior art keywords
group
same
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL84409A
Other languages
English (en)
Other versions
IL84409A0 (en
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of IL84409A0 publication Critical patent/IL84409A0/xx
Publication of IL84409A publication Critical patent/IL84409A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL84409A 1986-11-14 1987-11-09 Imidazolidinone derivatives,their preparation and pharmaceutical compositions containing them IL84409A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27265586 1986-11-14

Publications (2)

Publication Number Publication Date
IL84409A0 IL84409A0 (en) 1988-04-29
IL84409A true IL84409A (en) 1991-12-15

Family

ID=17516947

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84409A IL84409A (en) 1986-11-14 1987-11-09 Imidazolidinone derivatives,their preparation and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US4886817A (xx)
EP (1) EP0268229B1 (xx)
JP (1) JPS63239281A (xx)
KR (1) KR930002488B1 (xx)
CN (1) CN1017245B (xx)
AT (1) ATE78033T1 (xx)
AU (1) AU597444B2 (xx)
CA (1) CA1304376C (xx)
DE (1) DE3780259T2 (xx)
DK (1) DK597687A (xx)
ES (1) ES2046193T3 (xx)
FI (1) FI90869C (xx)
GR (1) GR3005227T3 (xx)
HU (1) HU198199B (xx)
IE (1) IE61446B1 (xx)
IL (1) IL84409A (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
GB9224144D0 (en) * 1992-11-18 1993-01-06 Erba Carlo Spa Phenyl-imidazolidinone derivatives and process for their preparation
JP3916092B2 (ja) * 1993-09-17 2007-05-16 杏林製薬株式会社 イミダゾリジノン誘導体とその酸付加塩及び老年性痴呆症の治療薬
US7129359B2 (en) 2002-07-09 2006-10-31 National Health Research Institutes Imidazolidinone compounds
MXPA05013196A (es) * 2003-07-11 2006-03-09 Elbion Ag Metodo para tratar o evitar trastornos del sistema nervioso central con compuestos que tienen selectividad por la subunidad alfa 3 del receptor de benzodiazepina.
WO2005082054A2 (en) * 2004-02-26 2005-09-09 Sosei Co., Ltd. Combinations for the treatment of fungal infections
US7259174B2 (en) * 2004-05-25 2007-08-21 National Health Research Institutes Imidazolidinone compounds
WO2006078698A1 (en) * 2005-01-19 2006-07-27 Cengent Therapeutics, Inc. 2-imidazolone and 2-imidazolidinone heterocyclic inhibitors of tyrosine phosphatases
US8354434B2 (en) 2006-01-30 2013-01-15 Purdue Pharma L.P. Cyclourea compounds as calcium channel blockers
CA2660201C (en) * 2006-08-15 2016-05-03 Novartis Ag Organic compounds
AU2013206248B2 (en) * 2008-06-27 2016-06-23 Xenon Pharmaceuticals Inc. Organic compounds
US8420661B2 (en) * 2010-04-13 2013-04-16 Hoffmann-La Roche Inc. Arylethynyl derivatives
CN102840229B (zh) * 2012-08-31 2015-11-18 中国舰船研究设计中心 可调心螺旋桨轴承装置
UA116023C2 (uk) * 2013-07-08 2018-01-25 Ф. Хоффманн-Ля Рош Аг Етинільні похідні як антагоністи метаботропного глутаматного рецептора
UA118035C2 (uk) * 2013-10-07 2018-11-12 Сінгента Партісіпейшнс Аг Гербіцидні сполуки
KR102035048B1 (ko) 2015-06-03 2019-10-22 에프. 호프만-라 로슈 아게 에틴일 유도체

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ184081A (en) * 1976-06-01 1980-10-08 Velsicol Chemical Corp 1-thiazol-2-yl-1 3-imidazolidn-2-ones
US4604127A (en) * 1984-07-17 1986-08-05 Eli Lilly And Company Herbicidal pyridazinylimidazolidinone compounds
JPS6133172A (ja) * 1984-07-24 1986-02-17 Kotobuki Seiyaku Kk 1,3−置換−2−イミダゾリジノン誘導体,胃腸運動亢進剤及びその製造方法
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
AU568789B2 (en) * 1985-02-22 1988-01-07 Mitsui Toatsu Chemicals Inc. 3,3'-dinitrodiphenylether from m-dinitrobenzene
JPH06133172A (ja) * 1992-10-20 1994-05-13 Fujitsu General Ltd ファクシミリ装置

Also Published As

Publication number Publication date
DK597687D0 (da) 1987-11-13
EP0268229B1 (en) 1992-07-08
HUT45983A (en) 1988-09-28
AU597444B2 (en) 1990-05-31
FI90869B (fi) 1993-12-31
GR3005227T3 (xx) 1993-05-24
KR880006231A (ko) 1988-07-22
DE3780259T2 (de) 1992-12-24
EP0268229A3 (en) 1990-09-19
CA1304376C (en) 1992-06-30
HU198199B (en) 1989-08-28
IL84409A0 (en) 1988-04-29
JPS63239281A (ja) 1988-10-05
FI874865A (fi) 1988-05-15
IE873063L (en) 1988-05-14
FI874865A0 (fi) 1987-11-04
IE61446B1 (en) 1994-11-02
DE3780259D1 (de) 1992-08-13
CN87107864A (zh) 1988-08-31
ES2046193T3 (es) 1994-02-01
DK597687A (da) 1988-05-15
AU8112587A (en) 1988-05-19
EP0268229A2 (en) 1988-05-25
KR930002488B1 (ko) 1993-04-02
FI90869C (fi) 1994-04-11
JPH05396B2 (xx) 1993-01-05
US4886817A (en) 1989-12-12
ATE78033T1 (de) 1992-07-15
CN1017245B (zh) 1992-07-01

Similar Documents

Publication Publication Date Title
IL84409A0 (en) Imidazolidinone derivatives,their preparation and pharmaceutical compositions containing them
PT83647A (en) Process for the preparation of novel pharmaceutical benzimidazole derivatives and of pharmaceutical compositions containing the same
IE45256L (en) Quinazolone derivatives
FI870421A (fi) Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ATE89547T1 (de) Dopamin-vorlaeufer.
DE3882679T2 (de) Kardiovaskulaer aktive verbindungen.
EP0183848A4 (en) POLYACAHETEROCYCLIC COMBINATING UNITS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL COMPOSITION.
HUT70548A (en) Oxazolidone derivatives, process for producing them and pharmaceutical compositions containing them
DE68904102D1 (de) Antivirale tetrahydroimidazo(1,4)benzodiazepin-2-one.
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
ATE69228T1 (de) Amidabkoemmlinge.
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
IL106107A (en) Imidazolyl-substituted cyclohexane derivatives, their preparation and pharmaceutical compositions containing them
IL89537A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
ATE92037T1 (de) Kardiovaskulaer aktive verbindungen.
ES8607968A1 (es) Un derivado de tetrahidro- -carbolina

Legal Events

Date Code Title Description
RH Patent void